Please assess the completion status of the following clinical trial:

Trial Title: Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Body Mass Index (BMI) is between 30 kg/m² and 40 kg/m², inclusive.~* Subject indicated for liposuction or use of liposuction techniques for the removal of localized deposits of adipose tissues that do not respond to diet and exercise; specifically for the indication of body contouring in the areas of the hips, waist and upper abdomen. (As per the American Academy of Cosmetic Surgery's 2006 Guidelines for Liposuction Surgery developed by A joint Ad Hoc Committee of the American Society of Lipo-Suction Surgery (ASLSS) and the American Academy of Cosmetic Surgery (AACS))~* Subject is willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring/ circumference reduction/weight loss during the course of study participation.~* Subject is willing and able to maintain his or her regular (typical pre-study) diet and exercise regimen without effecting significant change in either direction during study participation~Exclusion Criteria:~* Body Mass Index (BMI) is less than 30 kg/m² or greater than 40 kg/m².~* Known cardiovascular disease such as cardiac arrhythmias, congestive heart failure.~* Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.~* Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc.~* Medical, physical, or other contraindications for body sculpting/weight loss.~* Current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.~* Any medical condition known to affect weight levels and/or to cause bloating or swelling.~* Diagnosis of, and/or taking medication for, irritable bowel syndrome.~* Active infection, wound or other external trauma to the areas to be treated with the laser.~* Known photosensitivity disorder.~* Current active cancer or currently receiving treatment for cancer.~* Pregnant or planning pregnancy prior to the end of study participation.~* Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in past two years.~* Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.~* Involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to weight-related and/or body shape issues.~* Participation in a clinical study or other type of research in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Erchonia Obesity Laser (Type: ACTIVE_COMPARATOR): The Erchonia® Obesity Laser is made up of 10 independent 17 milliWatts (mW), 532 nanometer (nm) green laser diodes, each diode positioned 120 degrees apart from the next with each titled at a 30 degree angle. The Erchonia® Obesity Laser is a pulsed wave variable frequency device.
- Placebo Laser (Type: PLACEBO_COMPARATOR): Laser device emitting sham green light that has no therapeutic effect.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete